Clinical Trials on Vitamin C Abnormal in Spain

Total 215 results

Gerencia de Atención Primaria, Madrid
Instituto de Salud Carlos III

Completed

Oral/Intramuscular B12 to Treat Cobalamin Deficiency (OB12)

Vitamin B 12 Deficiency

Spain
Valme University Hospital
Hospital General Universitario Elche; Hospital del SAS de Jerez; Clinica Universidad... and other collaborators

Completed

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions (FPSMON201401)

Chronic Hepatitis C Infection

Spain
Igenomix
Instituto Universitario IVI

Completed

Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility

Azoospermia | Abnormal Spermatogenesis

Spain
Fundacion SEIMC-GESIDA

Withdrawn

A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A (C-RESCUE)

HCV

Spain
Hospital Universitario Ramon y Cajal

Terminated

Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis (RIBACIR)

Chronic Hepatitis C

Spain
Fundación Pública Andaluza para la Investigación...

Completed

Role of Gut Microbiome in the Health Benefits (BEEROTA18)

Normal Population

Spain
Fundació Eurecat
Laboratorio Echevarne; Health Tech Bio Actives, S.L.U.

Recruiting

Effect of Methylcobalamin and Cyanocobalamin Consumption on Vitamin B12 Nutritional Status (NORMB12)

Vitamin B12 Nutritional Deficiency

Spain
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients (EARLY-HEP-C)

Hepatitis C | HIV

Spain
Hospital Carlos III, Madrid

Completed

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies (PILOT-NR)

HIV Infections | Chronic Hepatitis C

Spain
Anna Cruceta

Completed

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin (BOC-HIV)

HIV Infections | Hepatitis C | COINFECTION

Spain
Fundación Pública Andaluza para la gestión de la...

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4 (OPTIM)

Hepatitis C, Chronic

Spain
Hospital Universitari Vall d'Hebron Research Institute

Completed

Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) (SPLEEN-C)

Cirrhosis | Chronic Hepatitis C | Portal Hypertension

Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks (3D8)

Hepatitis C Infection

Spain
Universidad de Extremadura
University of Valencia

Completed

Conservative Treatment of Ingrown Toenail (TOCON)

Ingrown Nail | Nails, Abnormal

Spain
Fundación Pública Andaluza para la gestión de la...

Completed

Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals (Hepatitis)

Hepatitis C, Chronic

Spain
Digna Biotech S.L.

Completed

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Chronic Hepatitis C Virus Infection | Genotype 1 | Treatment-Experienced Patients | Relapses

Spain
Instituto de Investigación Marqués de Valdecilla
Ministerio de Economía y Competitividad, Spain

Unknown

Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC) (CICHepC)

Hepatitis C

Spain
Parc de Salut Mar

Completed

Multidisciplinary Support Program in Chronic Hepatitis C

Hepatitis C, Chronic

Spain
Hospital Clinic of Barcelona

Completed

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Liver Transplantation | Hepatitis C Virus Infection

Spain
Bristol-Myers Squibb

Terminated

Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

Hepatitis C | Chronic Hepatitis

Australia, Spain
Janssen R&D Ireland

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C | Genotype 4 Chronic Hepatitis C

Spain
European Vision Institute Clinical Research Network

Completed

Project Gullstrand - European Project for the Determination of Average Biometric Values of Human Eyes (Gullstrand)

Normal Subjects, Ametropia

Spain
Hospital Universitario de Valme
Instituto de Salud Carlos III

Unknown

Prediction of Liver-related Outcomes After HCV Cure

Hepatocellular Carcinoma | Hepatitis C, Chronic | Hepatic Decompensation | Sustained Virological Response | Direct-acting Antivirals

Spain
Hospital Vall d'Hebron

Completed

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Hepatitis C Recurrence After Liver Transplant

Spain
University Rovira i Virgili

Completed

The Association Between Restricted Ankle Joint Dorsiflexion and Dynamic Knee Valgus (TOBROD)

Knee Injuries | Adolescent Development | Movement, Abnormal | Ankle Injuries and Disorders

Spain
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients (SAEI_IFN_1)

HIV Infections | Hepatitis C, Chronic

Spain
Barcelona Institute for Global Health
Carlos III Health Institute

Completed

Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development (WALNUTs)

Neurobehavioral Manifestations | Vitamin/Nutritional Deficiency

Spain
Faes Farma, S.A.

Completed

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency (WORFEROL)

Vitamin D Deficiency | Vitamin D Insufficiency

Spain, France, Bulgaria, Czechia, Italy, Serbia, Slovakia
Hospital Mutua de Terrassa

Completed

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study (MIC project)

Inflammatory Bowel Diseases | Hepatitis C Virus Infection

Spain
University of La Laguna

Recruiting

Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C

Hepatitis C Virus Infection

Spain
Leonor Cuadra Llopart
Fundacio Salut i Envelliment UAB

Completed

The Effect of Supplementation of Vitamin D Deficiency in Older People With Acute Hip Fracture: (VITAMINA_D)

Vitamin D Deficiency | Hip Fracture

Spain
University of La Laguna

Completed

Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening

Hepatitis C Virus Infection

Spain
Jose L. Casado

Recruiting

Impact of Hypovitaminosis D on Bone Disease in HIV Infected Patients (PuraVIHta)

Hypovitaminosis D

Spain
sigma-tau i.f.r. S.p.A.
SciClone Pharmaceuticals

Completed

Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.

Chronic Hepatitis C

Spain, Italy, France, Germany, Greece
University of La Laguna

Recruiting

Acceptance and Feasibility of Hepatitis c Screening Strategies in Social Insertion Centers (TGSS_CIS)

Hepatitis C Virus

Spain
Fundacion IMIM

Completed

ADHEPTA Study: Adherence Questionnaire in Hepatitis C (ADHEPTA)

HIV Infection | Hepatitis C, Chronic

Spain
Miguel Santín

Completed

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients (CONTRA)

Chronic Hepatitis C

Spain
Hospitales Universitarios Virgen del Rocío
Bristol-Myers Squibb

Completed

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

HIV Infection | Hepatitis C, Chronic

Spain
Janssen R&D Ireland

Completed

A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Hepatitis C, Chronic

Spain, Germany, Poland
Janssen R&D Ireland

Withdrawn

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Renal Impairment | End-stage Renal Disease

France, Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Hepatitis C

Spain
Clinica Universidad de Navarra, Universidad de...
Pfizer

Completed

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatitis C Virus Chronic Infection

Spain
Janssen-Cilag International NV

Completed

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation (REPLACE)

Chronic Hepatitis C Virus (HCV) Infection

France, United Kingdom, Spain, Germany, Belgium, Austria
Valme University Hospital

Completed

Treatment Insulin Resistence in HCV G-1 Patient (TRIC-1)

Chronic Hepatitis C

Spain
MurciaSalud

Completed

Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD) (ACViD)

Asthma, Bronchial

Spain
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Liver Cirrhosis | HIV Infection | Hepatitis C Virus

Spain
Novartis Pharmaceuticals

Completed

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Chronic Hepatitis C Genotype-1 Relapse

Belgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
Valme University Hospital
Hospital Universitario de Canarias; Hospital Universitario Virgen Macarena; Hospital... and other collaborators

Unknown

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Hepatitis C, Chronic | Human Immunodeficiency Virus

Spain
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Post Liver Transplant | Recurrent Chronic Hepatitis C Virus

United States, Spain, New Zealand, France, Germany
Fundación Pública Andaluza Progreso y Salud
Gilead Sciences

Completed

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." (hEPAtic)

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

Spain

3

Subscribe